Back to Products

MONEAST-FX

Fexofenadine Hydrochloride (120 mg), Montelukast (10 mg)

More products withFexofenadineMontelukast

Quantity
Prefer to talk?WhatsAppCall

Empower your clinical outcomes with MONEAST-FX, containing Fexofenadine Hydrochloride (120 mg), Montelukast (10 mg), manufactured under strict WHO-GMP compliance by Ramitra Biotech in 10 x 10 Aluminium packing to ensure maximum purity and bioavailability.

📋 Specifications

Product NameMONEAST-FX
CompositionFexofenadine Hydrochloride (120 mg), Montelukast (10 mg)
CategoryTablet
Packaging10 x 10 Aluminium
CertificationsWHO-GMP Certified / ISO 9001:2015 Approved
Franchise AvailabilityAvailable for PCD Franchise

Product Indications & Details

MONEAST-FX Tablets feature an advanced combination of Fexofenadine Hydrochloride 120 mg and Montelukast 10 mg for comprehensive allergy relief.
Conveniently supplied in a high-quality 10 x 10 aluminium-aluminium packaging designed to preserve drug potency and ensure optimal stability.
Fexofenadine Hydrochloride provides fast-acting non-drowsy antihistamine relief from common symptoms such as sneezing, runny nose, and watery eyes.
Montelukast functions as a potent leukotriene receptor antagonist that reduces airway inflammation and controls allergic respiratory symptoms.
Specially formulated by Ramitra Biotech to offer effective 24-hour management of seasonal and perennial allergic rhinitis.
Manufactured under strict quality assurance standards to guarantee clinical safety, consistency, and high patient compliance.